Controlled-Release Dosage Forms for Diltiazem Hydrochloride

Published on: 
Pharmaceutical Technology, Pharmaceutical Technology-04-02-2004, Volume 28, Issue 4

The authors investigate whether an extrusion-spheronization proces can be used to develop a matrix-based, controlled-release formulation for a highly water-soluble drug.

Related Content:

DevelopmentFormulation and Drug Delivery, Solid DosagePharmaceutical Technology-04-02-2004
CordenPharma Leverages Peptide Drug Discovery and Development with GENEPEP and Works on Reducing Emissions
Drug Digest: Transferring Energy to Hot Melt Extrusion
Charles River to Provide pDNA Manufacturing Services in Two Deals